Shanghai HeartCare (06609) Announces Share Repurchase and Updated Share Capital Structure

Bulletin Express

Jan 23

Shanghai HeartCare Medical Technology Corporation Limited (06609) disclosed an update to its share structure on 23 January 2026. The company repurchased 40,000 H shares and increased its treasury shares from 932,400 to 972,400. Following the transaction, the number of issued H shares (excluding treasury shares) decreased from 30,633,404 to 30,593,404, while the total issued shares (including unlisted shares) remained at 31,565,804.

According to the disclosure, the buyback occurred on 23 January 2026, with the repurchase price ranging from HKD 54.50 to HKD 57.45 per share and an aggregate purchase amount of HKD 2,258,165. The unlisted portion, consisting of 7,268,604 shares, remains unchanged. The company also confirmed that the share repurchase complied with all relevant regulations and received board authorization.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1100041945"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100041945\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100041945?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-23 18:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100041945","market":"us","top_or_hot":-1,"title":"Shanghai HeartCare (06609) Announces Share Repurchase and Updated Share Capital Structure","media":"Bulletin Express","content":"<p>Shanghai HeartCare Medical Technology Corporation Limited (06609) disclosed an update to its share structure on 23 January 2026. The company repurchased 40,000 H shares and increased its treasury shares from 932,400 to 972,400. Following the transaction, the number of issued H shares (excluding treasury shares) decreased from 30,633,404 to 30,593,404, while the total issued shares (including unlisted shares) remained at 31,565,804.</p>\n<p>According to the disclosure, the buyback occurred on 23 January 2026, with the repurchase price ranging from HKD 54.50 to HKD 57.45 per share and an aggregate purchase amount of HKD 2,258,165. The unlisted portion, consisting of 7,268,604 shares, remains unchanged. The company also confirmed that the share repurchase complied with all relevant regulations and received board authorization.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai HeartCare (06609) Announces Share Repurchase and Updated Share Capital Structure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai HeartCare (06609) Announces Share Repurchase and Updated Share Capital Structure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-23 18:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai HeartCare Medical Technology Corporation Limited (06609) disclosed an update to its share structure on 23 January 2026. The company repurchased 40,000 H shares and increased its treasury shares from 932,400 to 972,400. Following the transaction, the number of issued H shares (excluding treasury shares) decreased from 30,633,404 to 30,593,404, while the total issued shares (including unlisted shares) remained at 31,565,804.</p>\n<p>According to the disclosure, the buyback occurred on 23 January 2026, with the repurchase price ranging from HKD 54.50 to HKD 57.45 per share and an aggregate purchase amount of HKD 2,258,165. The unlisted portion, consisting of 7,268,604 shares, remains unchanged. The company also confirmed that the share repurchase complied with all relevant regulations and received board authorization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06609","symbol_name":"心玮医疗-B","start_time":0,"source_url":"","article_id":"1100041945","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100041945","pubTimestamp":1769162908,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai HeartCare Medical Technology Corporation Limited (06609) disclosed an update to its share structure on 23 January 2026. The company repurchased 40,000 H shares and increased its treasury...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06609":"心玮医疗-B"},"translate_title":"上海心康(06609)公布购回股份及更新股本架构","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06609":1},"content_text":"Shanghai HeartCare Medical Technology Corporation Limited (06609) disclosed an update to its share structure on 23 January 2026. The company repurchased 40,000 H shares and increased its treasury shares from 932,400 to 972,400. Following the transaction, the number of issued H shares (excluding treasury shares) decreased from 30,633,404 to 30,593,404, while the total issued shares (including unlisted shares) remained at 31,565,804.\nAccording to the disclosure, the buyback occurred on 23 January 2026, with the repurchase price ranging from HKD 54.50 to HKD 57.45 per share and an aggregate purchase amount of HKD 2,258,165. The unlisted portion, consisting of 7,268,604 shares, remains unchanged. The company also confirmed that the share repurchase complied with all relevant regulations and received board authorization.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}